Alpha-1 protease inhibitor and antichymotrypsin levels in acute pancreatitis;Akut pankreatitte alfa-1 proteaz inhibitorü ve antikimotripsin düzeyleri

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 18, Issue 3, 2012, Pages 195-199

  Karşidaǧ, Tamer ^a   Tüzün, Sefa ^a   Kemik, Ahu Sarbay ^b   Purisa, Sevim ^c   Ünlü, Aytekin ^d  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Division of Health   (Turkey)

Author keywords

Acute pancreatitis; Alpha 1 protease inhibitor; Antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLASE; C REACTIVE PROTEIN; CHYMOTRYPSIN INHIBITOR;

ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ALPHA 1-ANTITRYPSIN; AMYLASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84861720223     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: 10.5505/tjtes.2012.99075     Document Type: Article

References (19)

1. Tulp N. Observationum medicarum, Editio Nova et Aucta. 2nd ed. Amsterdam, The Netherland; 1652:345. Book 4. Cited by Howard JM, Hess W. History of the pancreas. New York: Kluwer; 2002.
2. Elman R, Arneson N, Graham EA. Value of blood amylase estimations in the diagnosis of pancreatic disease: a clinical study. Arch Surg 1929;19:943-967.
3. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993;128:586-590.
4. Chen CC. Serum markers in the early assessment of severity of acute pancreatitis: which is the most useful? J Chin Med Assoc 2004;67:439-441.
5. Ohlsson K, Olsson AS. Purification and partial characterization of human pancreatic elastase. Hoppe Seylers Z Physiol Chem 1976;357:1153-1161.
6. Adham NF, Dyce B, Haverback BJ. Trypsin-binding -2-macroglobulin in patients with acute pancreatitis. Gastroenterology 1972;62:365-372.
7. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991;6:253-259.
8. Heath DI, Wilson C, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994;35:1311-1315.
9. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997;41:832-840.
10. Mayer J, Rau B, Grewe M, Schoenberg MH, Nevalainen TJ, Beger HG. Secretory phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 1998;17:272-277.
11. Gross V, Leser HG, Heinisch A, Schölmerich J. Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522-530.
12. McMahon MJ. Plasma markers of pancreatic necrosis. In: Bradley EL III editor. Acute pancreatitis: diagnosis and therapy. New York: Raven Press; 1994. p. 47-55.
13. Banks RE, Evans SW, Alexander D, Van Leuven F, Whicher JT, McMahon MJ. Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulinprotease complexes in severe and mild attacks. Gut 1991;32:430-434.
14. Goodman AJ, Bird NC, Johnson AG. Antiprotease capacity in acute pancreatitis. Br J Surg 1986;73:796-798.
15. Hedström J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schröder T, et al. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. BMJ 1996;313:333-337.
16. McMahon MJ, Bowen M, Mayer AD, Cooper EH. Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 1984;147:164-170.
17. Lasson A, Ohlsson K. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984;19:779-786.
18. Ranson JH. Diagnostic standards for acute pancreatitis. World J Surg 1997;21:136-142.
19. Viedma JA, Pérez-Mateo M, Agulló J, Domínguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994;35:822-827.